2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding

Details for Australian Patent Application No. 2005245470 (hide)

Owner FoldRx Pharmaceuticals, Inc.

Inventors Labaudiniere, Richard

Agent Cullen & Co

Pub. Number AU-A-2005245470

PCT Pub. Number WO2005/113523

Priority 60/573,720 20.05.04 US

Filing date 20 May 2005

Wipo publication date 1 December 2005

International Classifications

C07D 263/57 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 307/91 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/113523 Priority application(s): WO2005/113523

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245492-Substituted quinoline derivatives as mitotic kinesin inhibitors

2005245467-Variously configurable rotating biological contactor and prefabricated components therefor